Recent Security Class Actions

Impax Laboratories, Inc. (NASDAQ: IPXL)

Company Name:Impax Laboratories, Inc.
Stock Symbol:NASDAQ: IPXL
Class Period Start:02/20/2014
Class Period End (inclusive):08/09/2016
Filing Deadline:01/09/2017

According to the law firm press release, the lawsuit alleges Defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Impax was engaging and/or had engaged in conduct that would cause the antitrust division of the U.S. Department of Justice ("DOJ") and the Connecticut Attorney General to conduct extensive investigations of possible collusion of generic drug pricing; (2) the DOJ investigation and the underlying conduct was likely to result in criminal charges against Impax, and possibly its officers and directors, for collusion of generic drug pricing; (3) Impax lacked effective internal controls over financial reporting; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.